DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC)
CUSIP: 25253X207
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Voting Common Shares, no par value
- Shares outstanding
- 52,272,727
- Total 13F shares
- 3,993,298
- Share change
- +1,187,753
- Total reported value
- $14,891,858
- Put/Call ratio
- 508%
- Price per share
- $3.73
- Number of holders
- 34
- Value change
- +$4,430,787
- Number of buys
- 16
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 25253X207?
CUSIP 25253X207 identifies DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 25253X207:
Top shareholders of DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
1.5%
|
787,536
|
$3,158,000 | — | 30 Sep 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.6%
|
311,041
|
$1,247,000 | — | 30 Sep 2021 | |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC |
13F
|
Company |
0.53%
|
275,000
|
$1,103,000 | — | 30 Sep 2021 | |
| Manatuck Hill Partners, LLC |
13F
|
Company |
0.52%
|
273,100
|
$1,095,000 | — | 30 Sep 2021 | |
| Leon G. Cooperman |
13F
|
Individual |
0.38%
|
200,000
|
$802,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
167,763
|
$672,000 | — | 30 Sep 2021 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
0.32%
|
165,775
|
$665,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.16%
|
85,570
|
$343,000 | — | 30 Sep 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.15%
|
80,600
|
$323,000 | — | 30 Sep 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.14%
|
74,280
|
$298,000 | — | 30 Sep 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.12%
|
60,429
|
$242,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.11%
|
55,970
|
$225,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.1%
|
49,884
|
$200,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.08%
|
39,717
|
$159,000 | — | 30 Sep 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.07%
|
35,854
|
$144,000 | — | 30 Sep 2021 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
30,904
|
$124,000 | — | 30 Sep 2021 | |
| Harry W. Alcorn Jr. |
3/4/5
|
SVP, Clinical Operations |
—
class O/S missing
|
43,981
|
$123,147 | — | 15 Sep 2021 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.05%
|
24,218
|
$97,000 | — | 30 Sep 2021 | |
| Jump Financial, LLC |
13F
|
Company |
0.04%
|
18,300
|
$73,000 | — | 30 Sep 2021 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.03%
|
16,341
|
$70,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
11,400
|
$46,000 | — | 30 Sep 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.02%
|
10,031
|
$40,000 | — | 30 Sep 2021 | |
| Shay Capital LLC |
13F
|
Company |
0.02%
|
10,000
|
$40,000 | — | 30 Sep 2021 | |
| MassMutual Private Wealth & Trust, FSB |
13F
|
Company |
0.01%
|
4,824
|
$19,000 | — | 30 Sep 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
4,616
|
$19,000 | — | 30 Sep 2021 | |
| US BANCORP \DE\ |
13F
|
Company |
0.01%
|
4,335
|
$17,000 | — | 30 Sep 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
2,305
|
$9,000 | — | 30 Sep 2021 | |
| Newbridge Financial Services Group, Inc. |
13F
|
Company |
0%
|
1,510
|
$6,000 | — | 30 Sep 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,470
|
$6,000 | — | 30 Sep 2021 | |
| Patriot Financial Group Insurance Agency, LLC |
13F
|
Company |
0%
|
1,200
|
$5,000 | — | 30 Sep 2021 | |
| GABLES CAPITAL MANAGEMENT INC. |
13F
|
Company |
0%
|
542
|
$2,000 | — | 30 Sep 2021 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
230
|
$922 | — | 30 Sep 2021 | |
| Sydney A. Gilman |
3/4/5
|
VP, Regulatory Affairs |
—
class O/S missing
|
25,000
|
— | — | 28 Jul 2021 |
Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q4 2021
As of 31 Dec 2021,
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,993,298 shares.
The largest 10 holders included
Stonepine Capital Management, LLC, VANGUARD GROUP INC, COOPERMAN LEON G, JACOB ASSET MANAGEMENT OF NEW YORK LLC, Ikarian Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, Manatuck Hill Partners, LLC, TWO SIGMA INVESTMENTS, LP, Anson Funds Management LP, and TWO SIGMA ADVISERS, LP.
This page lists
34
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
31
Q4 2021 holders
34
Holder diff
3
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.